Comparisons of perioperative outcomes and costs between open and laparoscopic radical prostatectomy: A propensity-score matching analysis based on the Japanese Diagnosis Procedure Combination database - Abstract

We compared perioperative outcomes and costs between open and laparoscopic radical prostatectomy for prostate cancer.

The Japanese Diagnosis Procedure Combination database, including cases from 2007 to 2010, was used by one-to-one propensity-score matching. The following items were compared: complication rate; homologous and autologous transfusion rate; first cystography day and cystography repeat rate; anesthesia time; postoperative length of stay; and costs. Multivariate analyses were carried out by including age, Charlson Comorbidity Index, T stage, hospital volume and hospital academic status as variables. As a result, among 15 616 open and 1997 laparoscopic radical prostatectomies, 1627 propensity-score matched pairs were generated. The laparoscopic approach showed a better overall complication rate (3.4% vs 5.0%), homologous transfusion rate (3.3% vs 9.2%), autologous transfusion rate (44.9% vs 79.3%), first cystography day (mean 6th vs 7th day), mean postoperative length of stay (mean 11 vs 13 days), and cost without surgery and anesthesia (mean $7965 vs $9235; all P < 0.001). Anesthesia time was longer (mean 345 vs 285 min) and total cost was higher (mean $14 980 vs $12 356) for the laparoscopic approach (both P < 0.001). The secondary cystography rates were comparable between the groups (18.3% vs 15.7%, P = 0.144). The multivariate analyses showed similar trends. In conclusion, these findings confirm several benefits of laparoscopy over open approach for radical prostatectomy.

Written by:
Sugihara T, Yasunaga H, Horiguchi H, Tsuru N, Ihara H, Fujimura T, Nishimatsu H, Ohe K, Fushimi K, Homma Y.   Are you the author?
Department of Urology, Shintoshi Hospital, Iwata; Department of Urology, The University of Tokyo, Tokyo, Japan.

Reference: Int J Urol. 2013 Jan 16. Epub ahead of print.
doi: 10.1111/iju.12079


PubMed Abstract
PMID: 23320826

UroToday.com Prostate Cancer Section